Menu
GeneBe

RCHY1

ring finger and CHY zinc finger domain containing 1, the group of Ring finger proteins

Basic information

Region (hg38): 4:75479032-75514764

Previous symbols: [ "ZNF363" ]

Links

ENSG00000163743NCBI:25898OMIM:607680HGNC:17479Uniprot:Q96PM5AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the RCHY1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the RCHY1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
4
clinvar
1
clinvar
5
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 4 1 1

Variants in RCHY1

This is a list of pathogenic ClinVar variants found in the RCHY1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
4-75482563-C-G not specified Uncertain significance (Mar 25, 2024)3313421
4-75482564-G-A not specified Likely benign (Mar 29, 2024)3313423
4-75482611-A-G not specified Uncertain significance (Jun 17, 2024)3313422
4-75482647-T-C not specified Uncertain significance (Apr 25, 2022)2373173
4-75509215-T-C not specified Uncertain significance (Nov 08, 2022)2323508
4-75509247-T-C not specified Uncertain significance (Jul 25, 2023)2589535
4-75514219-T-C not specified Uncertain significance (Jun 18, 2024)3313424
4-75514253-C-A not specified Uncertain significance (Dec 13, 2023)3152713
4-75514254-G-C not specified Likely benign (Jan 03, 2024)3152712
4-75514275-C-T Benign (May 15, 2018)775069

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
RCHY1protein_codingprotein_codingENST00000324439 935728
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.06620.9311257120361257480.000143
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.201011410.7150.000007011737
Missense in Polyphen3266.8020.47903798
Synonymous1.043746.00.8050.00000218427
Loss of Function2.63516.50.3027.81e-7221

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0008100.000749
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.0001910.000185
European (Non-Finnish)0.0001100.000105
Middle Eastern0.00005440.0000544
South Asian0.00006700.0000653
Other0.0002080.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Mediates E3-dependent ubiquitination and proteasomal degradation of target proteins, including p53/TP53, P73, HDAC1 and CDKN1B. Preferentially acts on tetrameric p53/TP53. Monoubiquitinates the translesion DNA polymerase POLH. Contributes to the regulation of the cell cycle progression. Increases AR transcription factor activity. {ECO:0000269|PubMed:16914734, ECO:0000269|PubMed:17721809, ECO:0000269|PubMed:18006823, ECO:0000269|PubMed:19043414, ECO:0000269|PubMed:19483087, ECO:0000269|PubMed:21791603, ECO:0000269|PubMed:21994467}.;
Pathway
p53 signaling pathway - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);Measles - Homo sapiens (human);DNA Repair;Immune System;Adaptive Immune System;p73 transcription factor network;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;AndrogenReceptor;Direct p53 effectors;Translesion Synthesis by POLH;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;DNA Damage Bypass (Consensus)

Recessive Scores

pRec
0.194

Intolerance Scores

loftool
0.489
rvis_EVS
-0.3
rvis_percentile_EVS
32.62

Haploinsufficiency Scores

pHI
0.349
hipred
Y
hipred_score
0.783
ghis
0.680

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.905

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Rchy1
Phenotype
cellular phenotype;

Gene ontology

Biological process
ubiquitin-dependent protein catabolic process;protein ubiquitination;positive regulation of protein ubiquitination;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;error-free translesion synthesis
Cellular component
ubiquitin ligase complex;nucleus;nucleoplasm;cytoplasm;cytosol;nuclear speck
Molecular function
p53 binding;ubiquitin-protein transferase activity;protein binding;zinc ion binding;protein homodimerization activity